Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.

about

Strategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering.

P2860

Q36399627-BBCB2D69-7B08-4CAB-BD27-8DC2085DA4CE

P2860

Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.

Item

http://www.wikidata.org/entity/Q46887367

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.

@en

Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.

@nl

type

Item

label

Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.

@en

Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.

@nl

prefLabel

Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.

@en

Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.

@nl

P1476

Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.

@en

P2093

Engel K

http://www.w3.org/2001/XMLSchema#string

Jakob T

http://www.w3.org/2001/XMLSchema#string

Reuter J

http://www.w3.org/2001/XMLSchema#string

Schempp CM

http://www.w3.org/2001/XMLSchema#string

Schulte Mönting J

http://www.w3.org/2001/XMLSchema#string

Seiler C

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.

Irritant patch testing with sodium lauryl sulphate: interrelation between concentration and exposure time.

Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus.

Skin reactions to irritants assessed by non-invasive bioengineering methods.

Pimecrolimus -- an anti-inflammatory drug targeting the skin.

Efficacy of skin barrier creams (III). The repetitive irritation test (RIT) in humans.

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

Variations of hair follicle size and distribution in different body sites.

Tacrolimus enhances irritation in a 5-day human irritancy in vivo model.

Tape stripping and sodium dodecyl sulfate treatment increase the molecular weight cutoff of polyethylene glycol penetration across murine skin.

P304

447-450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-3083.2007.02477.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18031501

http://www.w3.org/2001/XMLSchema#string

Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.

about

P2860

P2860

Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698